Silicon Laboratories Reports Fourth Quarter and Year End Results

January 26, 2011

Company Delivers Record Revenue for 2010

AUSTIN, Texas--(BUSINESS WIRE)-- Silicon Laboratories Inc. (Nasdaq: SLAB), a leader in high-performance, analog-intensive, mixed-signal integrated circuits (ICs), today reported revenue of $112 million for the fourth quarter and record revenue for the full year of $493 million.

2010 Highlights

  • Year over year growth was driven by record revenue for the company's broad-based products, which grew by nearly 50 percent over 2009 and represented 35 percent of total revenue for the year.
  • A sustained focus on R&D resulted in 17 new product family introductions during the year spanning MCUs, Embedded Wireless, Isolation, Human Interface, Timing, Video, AM/FM Radio and Power over Ethernet.
  • The company achieved a record number of design wins, broadened its sales channel and expanded its design team, all strong building blocks for future growth.
  • Gross margin on both a GAAP and non-GAAP basis was at record levels for the year resulting from cost improvements and mix shifts to broad-based products.
  • The company delivered 18 percent GAAP operating income and 26 percent non-GAAP operating income for the year.
  • Cash generation continued to be very strong, enabling $140 million in share repurchases, two strategic technology acquisitions and a year-end cash, cash equivalents and investments balance of $383 million.

Fourth Quarter Highlights

Fourth quarter revenue of $112 million exceeded guidance and represented a seven percent sequential decrease. The better than anticipated result for the quarter was due to stronger than anticipated demand for the company's broad-based products and the early stages of the company's ramp into iDTVs with its silicon TV tuner.

Fourth quarter GAAP gross margin was 63.5 percent. R&D investment increased to $32.6 million while SG&A decreased again to $27.5 million. Fully diluted GAAP earnings per share were $0.28 for the quarter.

The following non-GAAP results exclude the impact of stock compensation expense. Non-GAAP gross margin was 63.9 percent for the quarter. R&D investment increased sequentially to $28.5 million. SG&A expense declined to $22.8 million. Fully diluted non-GAAP earnings per share were $0.46. The reconciling charges are set forth in the financial measures table included below.

2011 Business Outlook

The company anticipates 2011 will be another growth year, with strong contributions from both the broadcast and broad-based businesses. Specifically, the company expects its video business to ramp and triple in size, while the timing business is expected to deliver high double-digit growth again in 2011. Both product lines are benefiting from new product ramps and an expanding footprint enabling strong market share gains.

"We believe the investments we've been making in our business over the last couple of years will begin delivering a strong return in 2011," said Necip Sayiner, president and CEO of Silicon Laboratories. "Organic new product developments complemented by strategic acquisitions like the SpectraLinear deal we announced today, have given us a platform for continually expanding our share of the market. We expect to benefit from such product cycles and are therefore anticipating a revenue increase of approximately four to nine percent in the first quarter."

The company guided revenue for the first quarter in the range of $116 to $122 million.

Webcast and Conference Call

A conference call discussing the quarterly results and the acquisition of SpectraLinear, also announced today, will follow this press release at 7:30 a.m. central time. An audio webcast will be available simultaneously on Silicon Laboratories' website under Investor Relations (www.silabs.com). A replay will be available after the call at the same website listed above or by calling 1 (800) 642-1687 or +1 (706) 645-9291 (international) and by entering 38360353. The replay will be available through February 9, 2011.

About Silicon Laboratories Inc.

Silicon Laboratories Inc. is a leading designer of high-performance, analog-intensive, mixed-signal integrated circuits (ICs) for a broad range of applications. Silicon Laboratories' diverse portfolio of highly integrated, patented solutions is developed by a world-class engineering team with expertise in cutting-edge mixed-signal design. The company has design, engineering, marketing, sales and applications offices throughout North America, Europe and Asia. For more information about Silicon Laboratories, please visit www.silabs.com.

Forward-Looking Statements

This press release contains forward-looking statements based on Silicon Laboratories' current expectations. The words "believe," "estimate," "expect," "intend," "anticipate," "plan," "project," "will" and similar phrases as they relate to Silicon Laboratories are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Laboratories and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: risks that Silicon Laboratories may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; volatile stock price; average selling prices of products may decrease significantly and rapidly; difficulties developing new products that achieve market acceptance; dependence on a limited number of products and customers; intellectual property litigation risks; inventory-related risks; risks associated with acquisitions; difficulties managing international activities; difficulties managing our manufacturers and subcontractors; risks that Silicon Laboratories may not be able to manage strains associated with its growth; credit risks associated with our accounts receivable; dependence on key personnel; risks associated with divestitures; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Laboratories' business and results of operations to risks of natural disasters, epidemics, war and political unrest; the competitive and cyclical nature of the semiconductor industry and other factors that are detailed in Silicon Laboratories' filings with the SEC. Silicon Laboratories disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Note to editors: Silicon Laboratories, Silicon Labs and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

 
 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Income

(In thousands, except per share data)

(Unaudited)

                 
    Three Months Ended   Year Ended
    January 1,

2011

  January 2,

2010

  January 1,

2011

  January 2,

2010

Revenues   $ 111,891     $ 127,190     $ 493,341     $ 441,020  
Cost of revenues     40,800       43,930       169,097       161,267  
Gross margin     71,091       83,260       324,244       279,753  
Operating expenses:                
Research and development     32,621       26,553       123,821       104,394  
Selling, general and administrative     27,456       30,629       113,752       108,848  
Operating expenses     60,077       57,182       237,573       213,242  
Operating income     11,014       26,078       86,671       66,511  
Other income (expense):                
Interest income     479       640       2,318       2,725  
Interest expense     (11 )     (25 )     (77 )     (180 )
Other income (expense), net     24       (388 )     (1,253 )     (90 )
Income before income taxes     11,506       26,305       87,659       68,966  
Provision (benefit) for income taxes     (1,377 )     (13,946 )     14,417       (4,126 )

Net income

  $ 12,883     $ 40,251     $ 73,242     $ 73,092  
                 
Earnings per share:                
Basic   $ 0.29     $ 0.88     $ 1.63     $ 1.62  
Diluted   $ 0.28     $ 0.84     $ 1.57     $ 1.57  
                 
Weighted-average common shares outstanding:                
Basic     43,834       45,650       44,845       45,023  
Diluted     45,658       47,786       46,742       46,542  
                                 
                                 
                                 

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except per share data)

                     
Non-GAAP Income Statement Items   Three Months Ended

January 1, 2011

    GAAP

Measure

  GAAP

Percent of Revenue

  Stock

Compensation Expense

  Non-GAAP

Measure

  Non-GAAP

Percent of Revenue

Revenues   $ 111,891                
                     
Gross margin     71,091     63.5 %   $ 361   $ 71,452   63.9 %
                     
Research and development     32,621     29.2 %     4,095     28,526   25.5 %
                     
Selling, general and                                
administrative     27,456     24.5 %     4,607     22,849   20.4 %
                     
Operating expenses     60,077     53.7 %     8,702     51,375   45.9 %
                     
Operating income     11,014     9.8 %     9,063     20,077   17.9 %
                     
                     
Non-GAAP Diluted Earnings Per Share   Three Months Ended

January 1, 2011

       
    GAAP

Measure

  Stock

Compensation Expense

  Non-GAAP

Measure

       
Net income   $ 12,883   $ 7,929     $ 20,812        
                     
Diluted shares outstanding     45,658     --       45,658        
                     
Diluted earnings per share   $ 0.28       $ 0.46        
                     
                     
Non-GAAP Income Statement Items   Year Ended

January 1, 2011

    GAAP

Measure

  GAAP

Percent of Revenue

  Stock

Compensation Expense

  Non-GAAP

Measure

  Non-GAAP

Percent of Revenue

Revenues   $ 493,341                
                     
Gross margin     324,244     65.7 %   $ 1,435   $ 325,679   66.0 %
                     
Operating income     86,671     17.6 %     40,324     126,995   25.7 %
                                 
                                 
                                 

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

         
    January 1,

2011

  January 2,

2010

Assets        
Current assets:        
Cash and cash equivalents   $ 138,567     $ 195,737  
Short-term investments     227,295       214,486  

Accounts receivable, net of allowance for doubtful accounts of

               
$772 at January 1, 2011 and $567 at January 2, 2010     45,030       56,128  
Inventories     39,450       31,512  
Deferred income taxes     9,140       7,620  
Prepaid expenses and other current assets     34,447       18,515  
Total current assets     493,929       523,998  
Long-term investments     17,500       24,676  
Property and equipment, net     29,945       27,785  
Goodwill     112,296       105,109  
Other intangible assets, net     53,242       41,886  
Other assets, net     20,746       19,384  
Total assets   $ 727,658     $ 742,838  
         
Liabilities and Stockholders' Equity        
Current liabilities:        
Accounts payable   $ 24,433     $ 28,759  
Accrued expenses     25,604       25,399  
Deferred income on shipments to distributors     26,127       28,470  
Income taxes     3,692       6,011  
Total current liabilities     79,856       88,639  
Long-term obligations and other liabilities     22,372       24,403  
Total liabilities     102,228       113,042  
Commitments and contingencies        
Stockholders' equity:        

Preferred stock--$0.0001 par value; 10,000 shares authorized; no

               
shares issued and outstanding     --       --  

Common stock--$0.0001 par value; 250,000 shares authorized;

               
43,933 and 45,772 shares issued and outstanding at                
January 1, 2011 and January 2, 2010, respectively     4       5  
Additional paid-in capital     49,947       128,262  
Retained earnings     579,127       505,885  
Accumulated other comprehensive loss     (3,648 )     (4,356 )
Total stockholders' equity     625,430       629,796  
Total liabilities and stockholders' equity   $ 727,658     $ 742,838  
                 
                 
                 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Cash Flows

(in thousands)

(Unaudited)

         
    Year Ended
    January 1,

2011

  January 2,

2010

Operating Activities        
Net income   $ 73,242     $ 73,092  
Adjustments to reconcile net income to cash provided by operating activities:        
Depreciation of property and equipment     11,797       11,887  
Loss on disposal of property and equipment     21       33  
Amortization of other intangible assets and other assets     7,494       7,842  
Stock compensation expense     40,324       43,974  
Income tax benefit from employee stock-based awards     3,295       2,422  
Excess income tax benefit from employee stock-based awards     (2,412 )     (1,862 )
Deferred income taxes     (552 )     1,896  
Changes in operating assets and liabilities:        
Accounts receivable     11,342       (19,657 )
Inventories     (7,811 )     (3,216 )
Prepaid expenses and other assets     (5,321 )     3,362  
Accounts payable     (777 )     8,036  
Accrued expenses     (2,590 )     (825 )
Deferred income on shipments to distributors     (2,343 )     6,871  
Income taxes     (7,774 )     (12,914 )
Net cash provided by operating activities     117,935       120,941  
         
Investing Activities        
Purchases of available-for-sale investments     (357,777 )     (237,968 )
Proceeds from sales and maturities of marketable securities     352,779       153,275  
Purchases of property and equipment     (13,850 )     (8,943 )
Purchases of other assets     (8,372 )     (6,408 )
Acquisitions of businesses, net of cash acquired     (28,021 )     (4,300 )
Net cash used in investing activities     (55,241 )     (104,344 )
         
Financing Activities        
Proceeds from issuance of common stock, net of shares withheld for taxes     18,055       25,187  
Excess income tax benefit from employee stock-based awards     2,412       1,862  
Repurchases of common stock     (140,331 )     (20,181 )
Net cash provided by (used in) financing activities     (119,864 )     6,868  
         
Increase (decrease) in cash and cash equivalents     (57,170 )     23,465  
Cash and cash equivalents at beginning of period     195,737       172,272  
Cash and cash equivalents at end of period   $ 138,567     $ 195,737  

 

Silicon Laboratories Inc.
Shannon Pleasant, 512-464-9254
shannon.pleasant@silabs.com

Source: Silicon Laboratories Inc.

News Provided by Acquire Media